alectinib

Alectinib (RG-7853) is an ALK inhibitor (IC50=1.9 nM, Kd=2.4 nM) that is selective, orally active, and ATP-competitive. Alectinib has antitumor activity and is used in the treatment of non-small cell lung cancer.

Alectinib hydrochloride (RO5424802 Hydrochloride) is a selective, and orally available inhibitor of ALK( IC50 : 1.9 nM)

Alectinib impurity 1 is an impurity of Alectinib.

Alectinib-D8 is a deuterated compound of Alectinib. Alectinib (T1936) has a CAS number of 1256580-46-7. CH5424802 is an orally available inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) with antineoplastic activity.

Alectinib M4 metabolite-d4 is the deuterium-labeled form of Alectinib M4 metabolite.

Alectinib hydrochloride (Standard) is a reference standard for research and analysis in studies involving Alectinib hydrochloride. Alectinib hydrochloride (RO5424802 Hydrochloride) is a selective, and orally available inhibitor of ALK( IC50 : 1.9 nM)

Alectinib-D8 (Standard) is a reference standard of Alectinib-D8 intended for quantitative analysis, quality control, and related biochemical research applications. Alectinib-d8 is a deuterated compound of Alectinib. Alectinib has a CAS number of 1256580-46-7. CH5424802 is an orally available inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) with antineoplastic activity.